---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-21-044718"
form_type: "8-K"
ticker: "KYNB"
cik: "0000921299"
company_name: "KYNTRA BIO, INC."
filed_at: "2021-08-16T23:59:59+00:00"
generated_at: "2026-06-29T10:51:59.429334+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# FibroGen announces CFO retirement of Pat Cotroneo; Juan Graham appointed effective Sept 7, 2021

## Summary
- Pat Cotroneo retires after 21 years; will serve as Executive Advisor to CEO through March 2022.
- Juan Graham becomes CFO Sept 7, 2021; previously Global CFO/VP Finance Supply Chain at Johnson & Johnson.
- Graham receives $470k base salary, 50% target bonus, 196k stock options, 35k RSUs, and up to $300k signing bonus.
- Relocation assistance up to $100k (grossed up) and eligibility for change-in-control severance agreement.
- No family relationships or related-party transactions disclosed with Mr. Graham.

## SEC filing metadata
- accession: 0001564590-21-044718
- form_type: 8-K
- ticker: KYNB
- cik: 0000921299
- company_name: KYNTRA BIO, INC.
- filed_at: 2021-08-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/921299/000156459021044718/0001564590-21-044718-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/921299/000156459021044718/fgen-8k_20210814.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-21-044718
- JSON: https://secwatch.observer/filing/0001564590-21-044718.json
- Plain text: https://secwatch.observer/filing/0001564590-21-044718.txt

## Key facts
- Executive change
  Juan Graham was appointed as Chief Financial Officer at KYNTRA BIO, INC..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: the appointment of Juan Graham as CFO, effective September 7, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/921299/000156459021044718/0001564590-21-044718-index.htm
- Executive change
  Pat Cotroneo retired as Chief Financial Officer at KYNTRA BIO, INC..
  - Action: retired
  - Role: Chief Financial Officer
  source text: retirement of Pat Cotroneo as Chief Financial Officer ("CFO")
  evidence_url: https://www.sec.gov/Archives/edgar/data/921299/000156459021044718/0001564590-21-044718-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.